Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Interest Income | 96,444 | 94,017 | 90,757 | 94,254 | 95,991 |
| Interest Expense | 13,896 | 13,603 | 13,863 | 18,147 | 20,683 |
| Interest Income (Net of Interest Expense) | 82,548 | 80,414 | 76,894 | 76,107 | 75,308 |
| Non-Interest Income | 31,890 | 42,003 | 37,566 | 31,227 | 46,698 |
| Sales | 114,438 | 122,417 | 114,460 | 107,334 | 122,006 |
| Credit Losses Provision | 0 | 0 | 0 | N/A | 2,000 |
| Non Interest Expenses | 85,334 | 81,678 | 81,929 | 89,589 | 89,408 |
| Pre-tax Income | 29,104 | 40,739 | 32,531 | 17,745 | 30,598 |
| Income Tax | 8,056 | 12,978 | 9,853 | -3,201 | 0 |
| Other Income | 43,000 | 54,342 | 46,394 | 35,892 | 51,281 |
| Net Income | $21,048 | $27,761 | $22,678 | $20,946 | $30,598 |
| EPS Basic Continuous Ops | 0.34 | 0.45 | 0.36 | 0.34 | 0.49 |
| EPS Basic Total Ops | 0.34 | 0.45 | 0.36 | 0.34 | 0.49 |
| EPS Diluted Continuous Ops | 0.33 | 0.44 | 0.36 | 0.32 | 0.49 |
| EPS Diluted Total Ops | 0.33 | 0.44 | 0.36 | 0.31 | 0.49 |
| EBITDA(a) | $N/A | $N/A | $N/A | $N/A | $N/A |